TRVI
NASDAQ · Pharmaceuticals
Trevi Therapeutics Inc
$14.26
-0.40 (-2.73%)
Open$14.14
Previous Close$14.66
Day High$14.44
Day Low$13.65
52W High$16.12
52W Low$5.38
Volume—
Avg Volume1.62M
Market Cap1.99B
P/E Ratio—
EPS$-0.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+53.8% upside
Current
$14.26
$14.26
Target
$21.93
$21.93
$18.04
$21.93 avg
$33.12
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 772.80M | 683.27M | 746.33M |
| Net Income | 98.54M | 104.02M | 99.75M |
| Profit Margin | 12.8% | 15.2% | 13.4% |
| EBITDA | 196.14M | 177.32M | 185.79M |
| Free Cash Flow | 50.24M | 55.58M | 60.41M |
| Rev Growth | +0.7% | +7.7% | +15.7% |
| Debt/Equity | 0.64 | 0.66 | 0.70 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |